A systematic review of bacteremias in cellulitis and erysipelas

Journal of Infection

Volumn 64, Issue 2, 2012, Pages 148-155

  Gunderson, Craig G ^a,b   Martinello, Richard A ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Cellulitis; Erysipelas; Soft tissue infections

Indexed keywords

BACTEREMIA; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BETA HEMOLYTIC STREPTOCOCCUS; BLOOD CULTURE; CELLULITIS; DISEASE ASSOCIATION; ERYSIPELAS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; STREPTOCOCCUS PYOGENES; SYSTEMATIC REVIEW;

BACTEREMIA; CELLULITIS; ERYSIPELAS; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 84855889062     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.11.004     Document Type: Review

References (50)

1. Swartz M.N. Clinical practice. Cellulitis. N Engl J Med Feb 26, 2004, 350(9):904-912.
2. Stevenson A., Hider P., Than M. The utility of blood cultures in the management of non-facial cellulitis appears to be low. N Z Med J Mar 11, 2005, 118(1211):U1351.
3. Bisno A.L., Stevens D.L. Streptococcal infections of skin and soft tissues. N Engl J Med Jan 25, 1996, 334(4):240-245.
4. Swartz M.N. Skin and soft tissue infections. Principles and practice of infectious diseases 2000, vol 1:1037-1057. Churchill Livingstone, Philadelphia. 5th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
5. Stevens D.L., Bisno A.L., Chambers H.F., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis Nov 15, 2005, 41(10):1373-1406.
6. Klein E., Smith D.L., Laxminarayan R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg Infect Dis Dec 2009, 15(12):1925-1930.
7. Moet G.J., Jones R.N., Biedenbach D.J., Stilwell M.G., Fritsche T.R. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis Jan 2007, 57(1):7-13.
8. King M.D., Humphrey B.J., Wang Y.F., Kourbatova E.V., Ray S.M., Blumberg H.M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med Mar 7, 2006, 144(5):309-317.
9. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med Aug 17, 2006, 355(7):666-674.
10. Gupta K., Macintyre A., Vanasse G., Dembry L.M. Trends in prescribing beta-lactam antibiotics for treatment of community-associated methicillin-resistant Staphylococcus aureus infections. J Clin Microbiol. Dec 2007, 45(12):3930-3934.
11. Jenkins T.C., Sabel A.L., Sarcone E.E., Price C.S., Mehler P.S., Burman W.J. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clin Infect Dis Oct 15, 2010, 51(8):895-903.
12. Gorwitz R.J. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis Mar 15, 2007, 44(6):785-787.
13. Liu C., Bayer A., Cosgrove S.E., et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis Feb 2011, 52(3):e18-e55.
14. Figtree M., Konecny P., Jennings Z., Goh C., Krilis S.A., Miyakis S. Risk stratification and outcome of cellulitis admitted to hospital. J Infect Jun 2010, 60(6):431-439.
15. Lazzarini L., Conti E., Tositti G., de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect Dec 2005, 51(5):383-389.
16. Stevens D.L., Eron L.L. Cellulitis and soft-tissue infections. Ann Intern Med Jan 6, 2009, 150(1):ITC11.
17. Daum R.S. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med Jul 26, 2007, 357(4):380-390.
18. Chira S., Miller L.G. Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review. Epidemiol Infect Mar 2010, 138(3):313-317.
19. Deleo F.R., Otto M., Kreiswirth B.N., Chambers H.F. Community-associated meticillin-resistant Staphylococcus aureus. Lancet May 1, 2010, 375(9725):1557-1568.
20. Moellering R.C. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis Apr 1, 2008, 46(7):1032-1037.
21. Jeng A., Beheshti M., Li J., Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore) Jul 2010, 89(4):217-226.
22. Horowitz Y., Sperber A.D., Almog Y. Gram-negative cellulitis complicating cirrhosis. Mayo Clin Proc Feb 2004, 79(2):247-250.
23. Lipsky B.A., Berendt A.R., Deery H.G., et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis Oct 1, 2004, 39(7):885-910.
24. Siljander T., Karppelin M., Vahakuopus S., et al. Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis Mar 15, 2008, 46(6):855-861.
25. Bjornsdottir S., Gottfredsson M., Thorisdottir A.S., et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis Nov 15, 2005, 41(10):1416-1422.
26. Bergkvist P.I., Sjobeck K. Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study. Scand J Infect Dis 1997, 29(4):377-382.
27. Bishara J., Golan-Cohen A., Robenshtok E., Leibovici L., Pitlik S. Antibiotic use in patients with erysipelas: a retrospective study. Isr Med Assoc J Oct 2001, 3(10):722-724.
28. Eriksson B., Jorup-Ronstrom C., Karkkonen K., Sjoblom A.C., Holm S.E. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis Nov 1996, 23(5):1091-1098.
29. Jorup-Ronstrom C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986, 18(6):519-524.
30. Masmoudi A., Maaloul I., Turki H., et al. Erysipelas after breast cancer treatment (26 cases). Dermatol Online J 2005, 11(3):12.
31. Bernard P., Bedane C., Mounier M., Denis F., Catanzano G., Bonnetblanc J.M. Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique. Arch Dermatol Jun 1989, 125(6):779-782.
32. Figtree M., Konecny P., Jennings Z., Goh C., Krilis S.A., Miyakis S. Risk stratification and outcome of cellulitis admitted to hospital. J Infect Jun 2010, 60(6):431-439.
33. Siljander T., Karppelin M., Vahakuopus S., et al. Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis Mar 15, 2008, 46(6):855-861.
34. Baddour L.M., Bisno A.L. Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs. JAMA Feb 24, 1984, 251(8):1049-1052.
35. Bjornsdottir S., Gottfredsson M., Thorisdottir A.S., et al. Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis Nov 15, 2005, 41(10):1416-1422.
36. Goldgeier M.H. The microbial evaluation of acute cellulitis. Cutis Jun 1983, 31(6):649-650.
37. Ho P.W., Pien F.D., Hamburg D. Value of cultures in patients with acute cellulitis. South Med J Nov 1979, 72(11):1402-1403.
38. Hook E.W., Hooton T.M., Horton C.A., Coyle M.B., Ramsey P.G., Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med Feb 1986, 146(2):295-297.
39. Kielhofner M.A., Brown B., Dall L. Influence of underlying disease process on the utility of cellulitis needle aspirates. Arch Intern Med Nov 1988, 148(11):2451-2452.
40. Kulthanan K., Rongrungruang Y., Siriporn A., et al. Clinical and microbiologic findings in cellulitis in Thai patients. J Med Assoc Thai Jun 1999, 82(6):587-592.
41. Lentino J.R., Stachowski M., Strikas R., Parrillo P. Comparative efficacy of cefotiam versus cephalothin in the therapy of skin and soft tissue infections. Antimicrob Agents Chemother Jun 1984, 25(6):778-780.
42. Liles D.K., Dall L.H. Needle aspiration for diagnosis of cellulitis. Cutis Jul 1985, 36(1):63-64.
43. Lutomski D.M., Trott A.T., Runyon J.M., Miyagawa C.I., Staneck J.L., Rivera J.O. Microbiology of adult cellulitis. J Fam Pract Jan 1988, 26(1):45-48.
44. Peralta G., Padron E., Roiz M.P., et al. Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis Oct 2006, 25(10):619-626.
45. Perl B., Gottehrer N.P., Raveh D., Schlesinger Y., Rudensky B., Yinnon A.M. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis Dec 1999, 29(6):1483-1488.
46. Rescigno J., McCormick B., Brown A.E., Myskowski P.L. Breast cellulitis after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys Apr 30, 1994, 29(1):163-168.
47. Sachs M.K. The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults [Erratum appears in Arch Intern Med 1991 Feb;151(2):244]. Arch Intern Med Sep 1990, 150(9):1907-1912.
48. Simon M.S., Cody R.L. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med Nov 1992, 93(5):543-548.
49. Stalnikowicz R., Block C. The yield of blood cultures in a department of emergency medicine. Eur J Emerg Med Jun 2001, 8(2):93-97.
50. Woo P.C., Lum P.N., Wong S.S., Cheng V.C., Yuen K.Y. Cellulitis complicating lymphoedema. Eur J Clin Microbiol Infect Dis Apr 2000, 19(4):294-297.